Advertisement
Loading...

VolitionRx Limited

VNRX•AMEX
Healthcare
Medical - Diagnostics & Research
$2.00
$-0.20(-9.09%)
U.S. Market opens in 37h 52m

VolitionRx Limited (VNRX) Stock Overview

Explore VolitionRx Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.1M
P/E Ratio-0.58
EPS (TTM)$-4.40
ROE0.82%
Fundamental Analysis

AI Price Forecasts

1 Month$2.54
3 Months$0.72
1 Year Target$0.39

VNRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of VolitionRx Limited (VNRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.58 and a market capitalization of 11.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.91%
5-Day Change
-13.75%
1-Month Change
-39.47%
3-Month Change
-54.30%
6-Month Change
-68.73%
Year-to-Date (YTD) Change
-59.49%
1-Year Change
-77.18%
3-Year Change
-93.98%
5-Year Change
-97.03%
All-Time (Max) Change
-96.55%

Contact Information

https://www.volition.com
646 650 1351
13215 Bee Cave Parkway, Henderson, TX, 78738

Company Facts

85 Employees
IPO DateMar 2, 2012
CountryUS
Actively Trading

Frequently Asked Questions